172 related articles for article (PubMed ID: 354331)
21. Positive and negative symptoms, depression and social disability in chronic schizophrenia: a comparative trial of bromperidol and fluphenazine decanoates.
McLaren S; Cookson JC; Silverstone T
Int Clin Psychopharmacol; 1992 Nov; 7(2):67-72. PubMed ID: 1487623
[TBL] [Abstract][Full Text] [Related]
22. Fluspirilene in the treatment of non-hospitalized schizophrenic patients.
Soni SD
Curr Med Res Opin; 1977; 4(9):645-9. PubMed ID: 590024
[TBL] [Abstract][Full Text] [Related]
23. A comparative trail of fluphenazine decanoate and flupenthixol decanoate.
Haslam MT; Bromham BM; Schiff AA
Acta Psychiatr Scand; 1975 Feb; 51(2):92-100. PubMed ID: 1091124
[TBL] [Abstract][Full Text] [Related]
24. A double-blind clinical evaluation of different dose intervals with fluspirilene (IMAP).
Börger J; Van Epen JH; Dekkers A
Acta Psychiatr Belg; 1978; 78(2):383-91. PubMed ID: 354325
[TBL] [Abstract][Full Text] [Related]
25. Long-acting phenothiazines in alcoholism.
Kinnell HG
Lancet; 1977 Sep; 2(8039):659. PubMed ID: 71470
[No Abstract] [Full Text] [Related]
26. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].
Woggon B; Dick P; Fleischhauer HJ; Gmür M; Gruber G; Angst J; Heimann H
Int Pharmacopsychiatry; 1977; 12(4):193-209. PubMed ID: 22515
[TBL] [Abstract][Full Text] [Related]
28. Disturbances of liver function of long acting neuroleptic drugs.
Nolen WA; Börger J
Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):199-204. PubMed ID: 674355
[TBL] [Abstract][Full Text] [Related]
29. A retrospective evaluation of long-term fluspirilene (IMAP) treatment.
Tanghe A
Acta Psychiatr Belg; 1976 May; 76(3):480-90. PubMed ID: 1020683
[TBL] [Abstract][Full Text] [Related]
30. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
[No Abstract] [Full Text] [Related]
31. Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
McKane JP; Robinson AD; Wiles DH; McCreadie RG; Stirling GS
Br J Psychiatry; 1987 Sep; 151():333-6. PubMed ID: 3322467
[TBL] [Abstract][Full Text] [Related]
32. A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.
Quitkin F; Rifkin A; Klein DF
Psychopharmacol Bull; 1977 Jul; 13(3):27-9. PubMed ID: 329327
[No Abstract] [Full Text] [Related]
33. [A comparative study of the longacting neuroleptics perphenazin-enanthate and fluspirilene (author's transl)].
Tegeler J; Floru L
Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):357-65. PubMed ID: 504342
[TBL] [Abstract][Full Text] [Related]
34. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
[TBL] [Abstract][Full Text] [Related]
35. Pimozide versus fluphenazine in ambulatory schizophrenics: A 12-month comparison study.
Donlon PT; Swaback DO; Osborne ML
Dis Nerv Syst; 1977 Feb; 38(2):119-23. PubMed ID: 319967
[TBL] [Abstract][Full Text] [Related]
36. Depot fluphenazine decanoate and enanthate for schizophrenia.
David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
[TBL] [Abstract][Full Text] [Related]
37. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.
Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C
Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
Kurland AA; Dim BH; Olsson JE
Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
[No Abstract] [Full Text] [Related]
39. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
McClelland HA; Farquharson RG; Leyburn P; Furness JA; Schiff AA
Arch Gen Psychiatry; 1976 Dec; 33(12):1435-9. PubMed ID: 11760
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate].
Angst J; Woggon B
Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
